DISCUSSION
obesity, diabetes mellitus, abnormal blood sugar, diabetic, diabetes
OBESITY, DIABETES MELLITUS, INSULIN RESISTANCE, INSULIN SENSITIVITY, DIABETES
Emerging evidence from multiple studies supports the positive impact of chromium on managing abnormal blood sugar levels in diabetes. It is believed to enhance insulin sensitivity in cells, facilitating insulin-cell interactions [Studies have noted a consistent reduction in HbA1c and blood glucose levels following chromium supplementation, likely attributed to its enhancement of insulin sensitivity and improved glucose regulation [Furthermore, chromium plays a significant role in lipid reduction. Multiple studies have demonstrated a notable decrease in triglyceride levels and an improvement in the risk associated with central obesity without any adverse impact on liver or renal function [The study cohort had a mean age of 52.3±6.3 years, with 46.7% males and 53.3% females, aligning with similar studies [Both this study and others have suggested that chromium improves insulin sensitivity, leading to decreased blood sugar levels in diabetes patients [In contrast to the result of this research, a study reported no benefit from chromium supplementation in diabetic patients with different formulas [These discrepancies between studies may be due to differences in baseline insulin sensitivity (patients with insulin resistance respond better to chromium), quantity of chromium administered, study period, sample size, and type of diabetes mellitus [The present study demonstrated a significant reduction in cholesterol serum levels over the study period (p-value=0.002). Additionally, the mean level of HDL increased following chromium supplementation (p-value=0.006). Although the mean level of triglycerides decreased, this difference did not reach statistical significance. These findings are consistent with the results of Ngala Plasma chromium levels can be influenced by various factors such as stress, diet, and exercise. Unfortunately, the potential impact of these confounding variables on chromium levels in our diabetes patient population could not be assessed.